Therapeutics (TGTX) 2025 Earnings Outlook for Investors
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Get up to date on 2024 wash sale rules for Dividend Etfs and how they affect harvesting strategies and reporting requirements.
15,526 articlesTG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
We set a bold goal—to buy our first rental properties with almost no money down. This guide shares the exact steps, l...
A Palm Springs estate once owned by Cary Grant has been listed for $12.7 million, offering collectors and investors a...
A single moment can ripple through your wallet. When Lionel Messi stood beside a world leader at a White House event,...
Solana is under renewed selling pressure as negative funding rates persist and on-chain inflows surge. Analysts warn ...
As Nvidia captures headlines with its chips, two AI software plays are quietly building durable demand. This article ...
A late-stage private AI company is inviting retail buyers to participate in a sub-$1 pre-IPO round, with shares at $0...
A headline like OpenAI Just Became Broadcom's New Chip Customer signals a dramatic turn in AI hardware. This article ...
Is Bitcoin really the better store value: bitcoin option, or do gold-backed stablecoins offer a compelling alternativ...
PropLogix launches PropOptix, a sales outreach platform that uses real-time market signals to connect title firms wit...
Iren has closed a $3 billion convertible notes sale at a 1% coupon, due 2033, to bankroll its AI cloud infrastructure...
KeyBanc boosted its outlook on CrowdStrike, lifting the price target to $700 after signals from the Mythos conference...